Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
Marquina G, Manzano A, Casado A. Marquina G, et al. Among authors: manzano a. Curr Oncol Rep. 2018 Apr 2;20(5):40. doi: 10.1007/s11912-018-0680-3. Curr Oncol Rep. 2018. PMID: 29611060 Review.
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.
Alcaraz-Sanabria A, Baliu-Piqué M, Saiz-Ladera C, Rojas K, Manzano A, Marquina G, Casado A, Cimas FJ, Pérez-Segura P, Pandiella A, Gyorffy B, Ocana A. Alcaraz-Sanabria A, et al. Among authors: manzano a. Front Oncol. 2020 Jan 10;9:1486. doi: 10.3389/fonc.2019.01486. eCollection 2019. Front Oncol. 2020. PMID: 31998644 Free PMC article.
A snapshot of COVID-19 infection in patients with solid tumors.
Fuentes-Antrás J, Manzano A, Marquina G, Paz M, Aguado C, Granja M, Benítez J, Ortega J, Priego A, González C, Tejerina-Peces J, Flores P, de Sa AL, Toledano C, Olalla J, de Luna A, Bartolomé J, Pérez-Segura P. Fuentes-Antrás J, et al. Among authors: manzano a. Int J Cancer. 2021 May 15;148(10):2389-2397. doi: 10.1002/ijc.33420. Epub 2020 Dec 19. Int J Cancer. 2021. PMID: 33270902 Free PMC article.
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Garcia Garcia Y, de Juan Ferré A, Mendiola C, Barretina-Ginesta MP, Gaba Garcia L, Santaballa Bertrán A, Bover Barcelo I, Gil-Martin M, Manzano A, Rubio Pérez MJ, Romeo Marin M, Arqueros Núñez C, García-Martínez E, Gonzalez Martin A. Garcia Garcia Y, et al. Among authors: manzano a. Int J Gynecol Cancer. 2019 Jul;29(6):1050-1056. doi: 10.1136/ijgc-2019-000256. Int J Gynecol Cancer. 2019. PMID: 31263024 Clinical Trial.
Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer.
Saiz-Ladera C, Baliu-Piqué M, Cimas FJ, Manzano A, García-Barberán V, Camarero SC, Hinojal GF, Pandiella A, Győrffy B, Stewart D, Cruz-Hernández JJ, Pérez-Segura P, Ocana A. Saiz-Ladera C, et al. Among authors: manzano a. Front Oncol. 2021 Oct 6;11:714550. doi: 10.3389/fonc.2021.714550. eCollection 2021. Front Oncol. 2021. PMID: 34692491 Free PMC article.
Novel targeted therapies in ovarian and uterine carcinosarcomas.
Han C, Altwerger G, Menderes G, Haines K, Feinberg J, Lopez S, Manzano A, Varughese J, Santin AD. Han C, et al. Among authors: manzano a. Discov Med. 2018 Jun;25(140):309-319. Discov Med. 2018. PMID: 30021104 Free article. Review.
244 results